© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#CROI 2021

Fatima Hassan and Gregg Gonsalves call for global COVID-19 vaccine access at CROI 2021 opening plenary
Another Year, Another Virtual CROI
vial and needle vaccine injection medication
Cabenuva Every Other Month Maintains Viral Suppression for Two Years
Click Here for CROI Online

New Vaccine Approaches Show Early Promise for HIV

Two experimental vaccine approaches, using mRNA protein delivery and germline targeting, are in the early stages of development.

Therapeutic Vaccines May Help Control HIV Off Treatment

HTI vaccines could become the backbone of a combination approach for achieving a functional cure.

Oral Antiviral Drug Effective Against COVID-19 in Hamsters

Molnupiravir, first developed for hepatitis C, might be able to prevent or treat COVID-19 outside of a clinical setting.

Can HIV Treatment Be Taken Just 4 Days a Week?

Taking meds for four days followed by three days off maintained viral suppression for two years.

More Than 1 in 3 New PrEP Prescriptions Were for Descovy in 2020

Plus, nearly a third of people already taking Truvada for PrEP switched to the new combination pill.

Dolutegravir Plus TAF Associated With Steepest Weight Gain

However, all integrase inhibitors were associated with similar weight gain.

MUST read

CROI 2020
CROI 2020 Coverage
CROI 2019 Coverage
illustration of multi-ethnic group of peple
All Conference Coverage

Community Collaboration Ups HIV Prevention Among Gay and Bi Black and Latino Men

13,000 gay and bi Black and Latino men received PrEP care through collaboratives.

My First CROI

I just attended my first CROI (Conference on Retroviruses and Opportunistic Infections). It was also my first virtual conference...

UPDATE: HIV and COVID-19 Conference CROI to Make Materials Public [VIDEO]

On April 15, full and free access to all virtual session recordings from the HIV and COVID-19 conference will be provided online.

HIV Diagnoses Among Native Americans Continue to Rise

However, even as new cases climbed, deaths declined.

Evidence Mounts for Dolutegravir Superiority in Children

Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.

Brazilian Man With HIV Is No Longer in Remission

The São Paulo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?
Illustration of hepatitis C virus (HCV)

Sexual Transmission of Hepatitis C Is Uncommon Among PrEP Users

Increased HCV testing and treatment for both HIV-positive and HIV-negative gay and bi men could help eliminate hep C.

Antiretrovirals for HIV Don’t Raise Birth Defect Risk

A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.

Mother-to-Child HIV Transmission Is Rare When Women Are on Treatment

Study results confirm that dolutegravir is a safe and effective treatment for pregnant women with HIV.

People Aging With HIV Expected to Have More Chronic Conditions

A new simulation suggests that by 2030, multimorbidity in people with HIV will rise substantially.
Advertisement
Science News
Features